Richard Gaynor
Hematology & Oncology · Indianapolis, INNPI 1033451083
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,867,571 of the $3,697,422 with a category attached, or 77.6%. Alkermes, Inc. accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Among hematology & oncology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $17,039 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$3.7M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$14
What the payments were for
- Consulting fees$2,867,57178%
- Speaking & faculty fees$767,97621%
- Travel & lodging$55,2541%
- Food & beverage$6,6210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 216 | $3,697,408 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
How this compares
$3,697,422 in reported general payments places this provider in the 95th percentile of 224 hematology & oncology providers in Indiana.
Other hematology & oncology in Indianapolis
- Ruemu BirhirayIndianapolis$3.1M
- Anand TandraIndianapolis$280K
- Attaya SuvannasankhaIndianapolis$253K
- Michael DuganIndianapolis$236K
- Daniel MiltonIndianapolis$231K
- Amro ElshouryIndianapolis$212K
- Brian MulherinIndianapolis$175K
- Muhammad Sarfraz NawazIndianapolis$172K
- John EdwardsIndianapolis$169K
- Karam Al-IssaIndianapolis$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.